CANCER TREATMENT CENTERS OF AMERICA and the National Football League Alumni Association announced a new partnership to raise awareness among NFL alumni and fans about screening, diagnosis and treatment for prostate cancer. The partnership also calls for CTCA to treat NFL alumni who are fighting the disease.
Over 50 research papers that list top leaders of Dana-Farber Cancer Institute among authors are implicated in an investigation of allegations of data manipulation.
Two major cancer informatics companies—Flatiron Health and Caris Life Sciences—have created a partnership to generate combined biological and clinical real-world evidence datasets that can be used to inform the development of immuno-oncology agents and targeted cancer therapeutics.
The process of navigating the cancer care continuum can be extremely complex, confusing, and frustrating for patients and caregivers. To achieve better outcomes, patients need to not only be aware of their options, but also have a comprehensive understanding of them and be able to act accordingly and with purpose.
The story of Janet Woodcock’s illustrious career is not just one of professional achievements; it’s a tale of enduring partnerships, empathetic leadership, and unwavering commitment to science and patient care that will continue as she leaves public service this year.
Shikhar Mehrotra, professor of surgery and Cecilia and Vincent Peng Endowed Chair in melanoma and cutaneous oncology, will take on the role of co-leader of the Cancer Biology and Immunology Research Program at MUSC Hollings Cancer Center, alongside Philip Howe, professor and chair of the Department of Biochemistry & Molecular Biology, and Sophie Paczesny, professor in the Department of Microbiology & Immunology.
Alexandra Miller, a neurologist and neuro-oncologist specializing in treating primary brain tumors, has been named as the chief of the Division of Neuro-Oncology and co-director of the Brain and Spine Tumor Center at NYU Langone Health’s Perlmutter Cancer Center, effective Jan. 29.
A research team from Louisiana State University LCMC Health Cancer Center has been awarded a $1.5 million grant to eliminate barriers from cervical cancer prevention.
Stacyann Bailey, assistant professor of biomedical engineering at the University of Massachusetts Amherst, has received a two-year grant from NCI to study the complex relationship between drugs used to treat metastatic cancer and the development of bone damage.
A 10-year follow-up study of nearly 2,500 U.S. men who received prostate cancer treatment will help inform decision-making in terms of treatments and side effects for a diverse population.
